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Previous studies reported enhanced cerebrovascular CO2 reactivity upon ascent to high
altitude using linear models. However, there is evidence that this response may be
sigmoidal in nature. Moreover, it was speculated that these changes at high altitude are
mediated by alterations in acid-base buffering. Accordingly, we reanalyzed previously
published data to assess middle cerebral blood flow velocity (MCAv) responses to
modified rebreathing at sea level (SL), upon ascent (ALT1) and following 16 days of
acclimatization (ALT16) to 5260m in 21 lowlanders. Using sigmoid curve fitting of the
MCAv responses to CO2, we found the amplitude (95 vs. 129%, SL vs. ALT1, 95%
confidence intervals (CI) [77, 112], [111, 145], respectively, P = 0.024) and the slope of
the sigmoid response (4.5 vs. 7.5%/mmHg, SL vs. ALT1, 95% CIs [3.1, 5.9], [6.0, 9.0],
respectively, P = 0.026) to be enhanced at ALT1, which persisted with acclimatization
at ALT16 (amplitude: 177, 95% CI [139, 215], P < 0.001; slope: 10.3%/mmHg, 95% CI
[8.2, 12.5], P = 0.003) compared to SL. Meanwhile, the sigmoidal response midpoint
was unchanged at ALT1 (SL: 36.5mmHg; ALT1: 35.4mmHg, 95% CIs [34.0, 39.0],
[33.1, 37.7], respectively, P = 0.982), while it was reduced by ∼7mmHg at ALT16
(28.6mmHg, 95% CI [26.4, 30.8], P = 0.001 vs. SL), indicating leftward shift of the
cerebrovascular CO2 response to a lower arterial partial pressure of CO2 (PaCO2)
following acclimatization to altitude. Sigmoid fitting revealed a leftward shift in the
midpoint of the cerebrovascular response curve which could not be observed with linear
fitting. These findings demonstrate that there is resetting of the cerebrovascular CO2
reactivity operating point to a lower PaCO2 following acclimatization to high altitude.
This cerebrovascular resetting is likely the result of an altered acid-base buffer status
resulting from prolonged exposure to the severe hypocapnia associated with ventilatory
acclimatization to high altitude.
Keywords: cerebral blood flow, cerebral blood flow regulation, cerebral hemodynamics, high altitude, transcranial
Doppler
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INTRODUCTION
During metabolic and respiratory-mediated pH perturbations,
both cerebral blood flow (CBF) and ventilation can be expressed
as a single linear function of the hydrogen ion concentration
([H+] in extracellular fluid, and therefore cerebrospinal fluid
(CSF) (Mitchell et al., 1965; Pappenheimer et al., 1965; Fencl et al.,
1966, 1969; Skinhoj, 1966; Betz and Heuser, 1967; Severinghaus
and Lassen, 1967; Lassen, 1968; Kontos et al., 1977; Warner et al.,
1987; Smith et al., 1988; Toda et al., 1989). Since bicarbonate
(HCO−3 ) is the main buffer base in the CSF compartment (Siesjö,
1972), changes in partial pressure of arterial carbon dioxide
(PaCO2) will lead to corresponding changes in [H
+] unless
compensatory adjustment in [HCO−3 ] occurs (Mitchell et al.,
1965). Accordingly, CSF [HCO−3 ] is an important determinant
of cerebrovascular and ventilatory responses during respiratory
acid-base disturbances.
During prolonged exposure to hypoxia, the hyperventilation-
induced hypocapnia and associated respiratory alkalosis lead
to a compensatory renal HCO−3 excretion, thereby lowering
[HCO−3 ] and returning pH toward homeostatic values in the
arterial and CSF compartment (Dempsey et al., 1974, 1975,
1978; Forster et al., 1975). At sea-level, reducing CSF [HCO−3 ]
with oral ammonium chloride administration increases the
cerebrovascular and ventilatory responsiveness to CO2, and
elicits a resetting of these responses to lower PaCO2 values (Fencl
et al., 1969). This reduction in CSF [HCO−3 ] and associated base
buffering change leads to a greater increase in [H+] for a given
rise in PaCO2 (Siesjö, 1972). Such changes in acid-base buffering
in the CSF compartment accounts for the enhanced CBF and
ventilatory responsiveness to CO2 observed at high altitude
(Mathew et al., 1983; Schoene et al., 1990; Fan et al., 2014),
along with the leftward shift in the ventilatory CO2 sensitivity
(Crawford and Severinghaus, 1978;Mathew et al., 1983; Fan et al.,
2012, 2014). Pioneering work by Severinghaus (1965) estimated
that CBFwould be 78% above pre-altitude values if arterial partial
pressures of O2 (PaO2) and CO2 were returned to sea-level values
following 3–5 days at 3800m. Similarly, data from Fan et al.
(2010, 2012) indicated a leftward shift in the CBF response to
CO2 following prolonged high altitude exposure. Since there
is a delayed onset of compensatory metabolic acidification we
would expect to observe no such resetting of the cerebrovascular
CO2 reactivity during acute high altitude exposure. However,
no studies have identified the magnitude of this cerebrovascular
resetting during acute and chronic exposure to high altitude.
Under constant arterial blood pressure, the overall
relationship of PaCO2 and CBF is sigmoidal with a linear
portion between PaCO2 of 25–65mmHg (Madden, 1993). While
the majority of the literature is focused on the linear portion
of this response, sigmoid fitting might be more appropriate
for the assessment of cerebrovascular CO2 reactivity at high
altitude due to the severe hypocapnia resulting from ventilatory
acclimatization to high altitude. Further, the use of a linear
model may miss a number of physiological parameters (e.g.,
the optimal operating point) and physical constraints of the
cerebral vasculature (e.g. vessels’ finite dilation/constriction and
associated vascular reserves; Battisti-Charbonney et al., 2011).
Accordingly, sigmoid curve fitting could provide additional
insight to the changes in cerebrovascular CO2 reactivity at high
altitude (such as changes in vascular dilation or constriction
reserves and a shifting of the operating point).
Using the sigmoid curve fitting method described by Battisti-
Charbonney et al. (2011), we reanalyzed our cerebrovascular CO2
reactivity data from rebreathing tests as previously reported in
Fan et al. (2014). We tested the hypotheses that: (1) ascent to high
altitude is accompanied by a leftward shift as well as an increase in
the cerebrovascular response to CO2 upon ascent to 5260m and
following acclimatization; (2) these changes in cerebrovascular
CO2 reactivity would be abolished once we account for the acid-
base change by plotting CBF against [H+] instead of PCO2; and
(3) the use of sigmoid fitting will reveal changes in vascular
reserve at high altitude.
MATERIALS AND METHODS
Subject Recruitment and Screening
This study was conducted as part of the AltitudeOmics project.
Following institutional ethics approval, young (19–23 years old),
healthy, sea level residents were recruited from the greater
Eugene, Oregon area (elevation 130 m). Potential subjects were
screened to exclude anyone who was born or had lived at
altitudes >1500m for more than 1 year or had traveled to
altitudes >1000m in the past 3 months. After obtaining written
consent, physical exams and the Army Physical Fitness Test
(push-ups, sit-ups, and a 3.2-km run) were performed to verify
health and fitness status (Subudhi et al., 2014b).
Ethical Approval
The study was performed according to the Declaration of
Helsinki and was approved by the Institutional Review Boards
of the Universities of Colorado and Oregon and by the Human
Research Protection Office of the U.S. Department of Defense.
All participants were informed regarding the procedures of
this study, and written informed consent was given prior to
participation.
Experimental Design
After familiarization with the experimental procedures outlined
below (visit one), twenty-one subjects underwent three
experimental trials: near sea level (SL: 130 m, barometric
pressure: 749mmHg) and on day 1 and 16 following ascent to
5260m (ALT1 and ALT16). Approximately 4 weeks following
SL measurements in Eugene, Oregon, the subjects were flown to
La Paz, Bolivia. They spent two nights at low altitude (1525m in
Coroico, Bolivia) before being driven to the Chacaltaya Research
Station at 5260 m, while breathing supplemental oxygen (ALT1).
Subjects acclimatized to altitudes ranging from 3800 to 5260m
over the next 15 days, with most of the time (75%) spent at
5260 m. On the 16th day (ALT16), measurements were repeated
(Subudhi et al., 2014b).
Experimental Protocol
A 22-gauge catheter was inserted into a radial artery at least
1 h prior to instrumentation. Subjects were seated in an upright
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position for 15min, while sensors were placed to measure
physiological variables of interest (Subudhi et al., 2014b).
Following 10–15min of quiet rest in a seated position, each
experimental testing session comprised of: (a) instrumentation;
(b) 10min room air baseline; (c) 10min steady-state with partial
pressure of end-tidal CO2 (PETCO2) and O2 (PETO2) clamped
at 40mmHg and 300mmHg, respectively, and (d) assessment
of cerebrovascular CO2 reactivity with a modified rebreathing
test. For each subject, all ALT measurements were carried out
around the same time of day to minimize any confounding effect
by circadian rhythm. Measurements were taken upon arrival
at ALT1 to minimize the influence of acute mountain sickness
(AMS). Likewise, no symptoms of AMS were observed at ALT16.
Throughout the protocol, the subjects sat upright and
breathed through a mouthpiece attached to a two-way non-
rebreathing valve (Hans-Rudolph 2700, Hans-Rudolph Inc.,
Shawnee, KS, USA). The breathing circuit allowed switching
from room air to either an end-tidal clamping system or a
rebreathing system.
Modified Rebreathing Method
The rebreathing bag was filled with gas to achieve inspired PCO2
and PO2 of 0 and 300mmHg, respectively, upon rebreathing
at each altitude. Hyperoxia was used to abolish the potentially
confounding influence of changes in PaO2 at SL, ALT1, and
ALT16 on our cerebrovascular CO2 reactivity estimates. Subjects
were instructed to hyperventilate for 3min to lower and then
maintain PETCO2 at∼18mmHg at both sea level and 5260m (in
background PETO2 >250mmHg). Subjects were then switched
to the rebreathing bag, and following two initial deep breaths to
mix the gas from the bag with that in the respiratory system, they
were instructed to breathe ad libitum. The rebreathing tests were
terminated when PETCO2 reached 50mmHg, PETO2 dropped
below 200mmHg or the subject reached the end of his/her
tolerance.
MEASUREMENTS
Cerebral Blood Flow Velocity
Middle cerebral artery velocity (MCAv, an index of cerebral
blood flow) was measured in the left middle cerebral artery
using a 2-MHz pulsed Doppler ultrasound system (ST3, Spencer
technology, Seattle, WA, USA). The Doppler ultrasound probe
was positioned over the left temporal window and held in
place with an adjustable plastic headband (Marc 600 Headframe,
Spencer technology, Seattle, WA, USA). The signal was acquired
at depths ranging from 43 to 54mm. Signal quality was optimized
and anM-mode screen shot was recorded to facilitate subsequent
probe placements.
Arterial Blood Pressure
Beat-to-beat arterial blood pressure (ABP) was measured from
an arterial catheter inserted in a radial artery, and connected to a
calibrated, fluid-filled, disposable pressure transducer positioned
at the level of the heart (DELTRAN II, Utah Medical, Salt Lake
City, UT, USA).
End-Tidal Gases
PETCO2 and PETO2 were measured using fast responding gas
analyzers (O2Cap Oxygen analyzer, Oxigraf, Mountain View,
CA, USA). The gas analyzers were calibrated using gas mixtures
of known concentrations of O2 and CO2 prior to each testing
session.
Arterial Blood Gases
For each subject, arterial blood samples were taken four times at
SL, ALT1 and ALT16 (room air breathing, PETCO2 clamped at
40mmHg, hyperventilation and end of rebreathing). Hydrogen
ion concentration ([H+]) was calculated from the arterial pH
values using the Siggaard-Andersen equation (OSA.exe, freely
available at http://www.siggaard-andersen.dk). The [H+] values
were plotted against PaCO2 (Figure 1) and the relationship
between these two variables was obtained using linear regression
(Prism 6.0b, GraphPad Software Inc., San Diego, CA, USA). The
equation of this [H+]-PaCO22 slope was subsequently used to
calculate the corresponding [H+] values for the range and the
midpoint of the sigmoid curves for each rebreathing maneuver
(Figure 1).
Data Acquisition
All analog data were sampled and recorded at 200Hz on a PC for
off-line analysis (ADInstruments Powerlab 16/30, Dunedin, New
Zealand).
DATA ANALYSIS
Rebreathing Analysis (Figure 2)
As first detailed by Battisti-Charbonney et al. (2011), the
following assumptions were made regarding the analysis
of the rebreathing data: (i) hyperventilation lowers PETCO2
sufficiently to produce full hypocapnia-induced vasoconstriction;
(ii) as PETCO2 increases from a hypocapnic value during
hyperventilation to increasingly hypercapnic values during
rebreathing, full vasodilation is achieved; the shape of this
relationship is assumed to be sigmoidal with a linear portion
FIGURE 1 | Representative example of [H+] plotted against PaCO2 at
sea level (SL), upon ascent (ALT1), and following 16 days
acclimatization to 5260m (ALT16) for one subject.
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in the middle of the curve (Claassen et al., 2007); and (iii)
as hypercapnia increases beyond the point of maximal CO2-
induced vasodilation, CBF becomes directly dependent on
perfusion pressure. Based on these assumptions, cerebrovascular
CO2 reactivity can be summarized as the vasodilatory and
vasoconstrictive response of the cerebral blood vessels. The
“midpoint” of the sigmoid curve then represents the optimal
point of the vessels’ capacity to dilate and constrict (i.e., the
optimal operating point), while the upper and lower plateaus of
the sigmoid response represent the physical constraints of the
cerebral vascular reserve. Meanwhile, the range of the sigmoid
curve reflects the PCO2 range of the linear portion of the sigmoid
curve, and the amplitude represents the overall extent of this
response.
The rebreathing data were first reduced to 1-s averages across
the entire rebreathing period. MCAv values were then converted
to a percentage change from MCAv values observed at resting
PETCO2. Since the ABP-CO2 response is enhanced at high
altitude (Ainslie and Burgess, 2008; Fan et al., 2014; Willie
et al., 2015) and known to potentially confound estimates of
cerebrovascular CO2 reactivity (Betz, 1968; Regan et al., 2014),
a PETCO2 threshold (TABP) was first identified as the point from
which mean ABP rose more than 0.5mmHg per mmHg change
in PETCO2. This threshold was identified by fitting the mean
ABP response to PETCO2, with two straight lines above and
below the TABP using linear regression, and restricting the slope
of the lower portion to < 0.5mmHg change in ABP per mmHg
change in PETCO2. The MCAv response to PETCO2 was then
divided into two portions below and above the TABP and the
portion ofMCAv-PETCO2 response below TABP was fitted with a
sigmoid curve as described by Battisti-Charbonney et al. (2011),
thereby minimizing the confounding influence of ABP on the
MCAv-CO2 response. To minimize the sum of squares for non-
linear regression (Levenberg-Marquardt algorithm) we used the
equation:
MCAv = minimum+ (amplitude/(1+ exp(−(PETCO2 −
midpoint)/range)))
Where MCAv is the dependent variable in %, PETCO2 is the
independent variable in mmHg, minimum is the minimum
MCAv determined from the mean MCAv of the hypocapnic
(hyperventilation) region, amplitude is the amplitude of the
response (i.e., the maximumMCAv value),midpoint is the PCO2
value at the center of the sigmoid curve, and range is the PCO2
range of the linear portion of the sigmoid (an inverse reflection
of the slope of the linear portion). The slope of the sigmoid curve
(i.e., cerebrovascular CO2 reactivity) is subsequently calculated
from the linear portion of the response. The vasoconstriction
reserve was calculated as the difference betweenminimumMCAv
and MCAv at resting PaCO2, while the vasodilation reserve
was calculated as the difference between the MCAv at TABP
(or amplitude if no TABP was observed during rebreathing)
and MCAv at resting PaCO2, expressed at percentage MCAv
(Figure 2).
The alignment and fitting processes were performed using
custom written graphic analysis routines (LabVIEW, Nation
Instruments, Austin, TX, USA). The fitting program provided an
r-square of the sigmoid and linear fits.
Statistical Analysis
Due to logistical impacts on planning and transportation, not all
subjects were able to participate in all high-altitude studies; please
see the Figures and Table for complete sample size reporting
for each procedure. After calculating descriptive statistics [mean,
95% confidence interval (CI)], mixed model linear regression
analysis (diagonal repeated covariance assumed) (IBM R© SPSS R©
Statistics version 21, IBM R© Corporation, Armonk, NY, USA)
was used to evaluate the effects of altitude exposure and
acclimatization (between SL, ALT1 and ALT16) on the midpoint,
amplitude and range of the fitted sigmoid curves. Post hoc tests
were performed on the midpoint, amplitude and range of the
sigmoid curves between SL, ALT1 and ALT16 using the Holm-
Sidak adjustment for multiple comparisons (α = 0.05) (IBM R©
SPSS R© Statistics version 21, IBM R© Corporation, Armonk, NY,
USA). Cohen’s d, as a measure of effect size, was calculated as
d = (M1 – M2)/SD, where M1 and M2 are means of group 1
and 2; SD is standard deviations of pooled data. The effect size
was considered negligible when d < 0.2, small when d ≥ 0.2,
moderate when d ≥ 0.5, large when d ≥ 0.8, and very large
when d ≥ 1.3 (Sullivan and Feinn, 2012). Results were considered
significant at the alpha level <0.05. A priori power calculations
(α = 0.05, β = 0.20) were used to determine sample size and
limit Type II error.
RESULTS
Detailed baseline characteristics of the 21 (nine women; age 21±
1 years) subjects participating in AltitudeOmics were presented
elsewhere (Subudhi et al., 2014a). All 21 subjects performed the
modified rebreathing test at SL and ALT16. However, 4 of the 21
subjects did not perform the modified rebreathing at ALT1. After
excluding data due to unstable ABP during rebreathing, 13, 9,
and 7 trials met the inclusion criteria at SL, ALT1, and ALT16,
respectively, and were included in the analysis. Sigmoid curve
FIGURE 2 | A representative example of an individual rebreathing test
and sigmoid curve fitting upon ascent to 5260m (ALT1).
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fitting was applied to the remaining trials with R2 of 0.89 ± 0.05
(mean± SD).
Cerebrovascular CO2 Reactivity
No difference was observed in the PETCO2 range of the linear
portion of the sigmoid between SL and ALT1 (d = 1.0, P =
0.149). Likewise, the PETCO2 range was unaltered following
acclimatization at ALT16 when compared to SL (d = 1.2, P =
0.060) or to ALT1 (d = 0.3, P = 0.149 vs. ALT1, Table 1). Upon
ascent to 5260m (ALT1), the amplitude of the MCAv response
was increased by ∼34% (d = 5.8, P = 0.024 vs. SL), and further
increased by ∼82% at ALT16 (d = 11.1, P < 0.001 vs. SL,
Table 1). However, the amplitude of the sigmoid MCAv response
was not different between ALT1 and ALT16 (d = 7.3, P = 0.101,
Table 1). As a result of these increases in amplitude of the MCAv
response, the linear portion of the sigmoid curve was enhanced
by ∼67% at ALT1 (d = 1.8, P = 0.026) and by ∼129% at ALT16
(d = 3.0, P = 0.003) compared to SL, while no difference was
observed fromALT1 to ALT16 (d = 1.7, P = 0.175,Table 1). The
PETCO2 midpoint of the sigmoid curve was unchanged upon
ascent to 5260m (d = 0.5, P = 0.982 vs. SL), while it was reduced
by ∼8mmHg (i.e., shifted leftward) following acclimatization at
ALT16 (d = 3.3, P = 0.001 vs. SL, Table 1). Accordingly, the
PETCO2 midpoint was lower at ALT16 by ∼7mmHg compared
to initial exposure to high altitude (d = 3.1, P = 0.005 vs.
ALT1,Table 1). These findings indicate that cerebrovascular CO2
reactivity was enhanced upon ascent to 5260 m, resulting in both
upward shifting and steeping of the sigmoid curve compared to
sea level (Figure 3). Following acclimatization, at ALT16, there
was a leftward shift of the sigmoid curve (Figure 4A), while,
cerebrovascular CO2 reactivity did not differ greatly between
ALT1 and ALT16 (Figure 3).
Compared to SL, the vasoconstriction reserve was lowered
by ∼31% at both ALT1 (d = 1.2, P = 0.008) and at ALT16 (d =
1.2, P = 0.012), while the vasodilation reserve was increased
by ∼83% at ALT1 (d = 1.67, P < 0.001) and by ∼92% at
ALT16 (d = 1.7, P < 0.001, Table 1). No differences were
observed between ALT1 and ALT16 for the constriction (d = 0.0,
P = 1.000) and dilation reserves (d = 0.2, P = 0.945, Table 1).
Acid-Base Buffering
When expressing MCAv against [H+], the range was unaltered
following ascent at ALT1 (d = 1.0, P = 0.137 vs. SL) or with
acclimatization at ALT16 (d = 0.9, P = 0.171), and no difference
in the [H+] range of the linear sigmoid portion was observed
between ALT1 and ALT16 (d = 0.2, P = 0.993, Table 1).
Similarly, the midpoint of the sigmoid curve occurred at similar
[H+] at SL, ALT1 (d = 0.0, P = 1.000 vs. SL) and ALT16
(d = 0.1, P = 0.999, Table 1). Meanwhile, cerebrovascular CO2
reactivity was enhanced upon ascent to ALT1 by∼78% (d = 2.4,
P = 0.012 vs. SL) and remained elevated at ALT16 (d = 3.4,
P = 0.004, Table 1). No difference was found in cerebrovascular
CO2 reactivity between ALT1 and ALT16 (d = 1.4, P = 0.396,
Table 1).
DISCUSSION
In the present study, we examined the changes in cerebrovascular
parameters during modified rebreathing using sigmoid curve
fitting analysis. Using sigmoid fitting, we found: (1) the increase
in cerebrovascular CO2 reactivity at ALT1 is mediated by
an enhanced sensitivity of the cerebral blood vessels to H+
(Figure 4B); (2) there is a leftward shift of MCAv-CO2 response
with acclimatization at ALT16 (Figure 4A), indicating a resetting
of the cerebrovascular CO2 reactivity sigmoid midpoint to a
lower PaCO2 with chronic hypoxia; (3) this leftward shift in
cerebrovascular CO2 reactivity is abolished once we account
for the changed acid-base buffering status; and 4) despite this
cerebrovascular resetting, the vascular constriction reserve is
reduced at high altitude. From our findings, it appears that this
cerebrovascular resetting to a lower range of PaCO2, mediated
by changes in acid-base buffering, is likely a serendipitous
consequence of acclimatization to high altitude. Importantly, this
resetting restores cerebrovascular control during the persistent
TABLE 1 | Sigmoid curve fitting parameters during modified rebreathing.
Variable SL ALT1 ALT16
n 13 9 7
Mean 95% CI Mean 95% CI Mean 95% CI
Amplitude (%) 95 [77–112] 129* [111–147] 177* [139–216]
Midpoint (mmHg) 36.5 [34.0–39.0] 35.4 [33.1–37.7] 28.6*† [26.4–30.8]
Range (mmHg) 5.9 [4.6–7.2] 4.5 [3.7–5.3] 4.2 [3.7–4.7]
Cerebrovascular CO2 reactivity (%/mmHg) 4.5 [3.1–5.9] 7.5* [6.0–9.0] 10.3* [8.2–12.5]
Constriction reserve (%) 56 [42–70] 25* [16–34] 25* [15–36]
Dilation reserve (%) 20 [7–34] 103* [82–125] 112* [84–139]
PLOTTED AGAINST [H+]
Midpoint (nEq/L) 37.5 [35.0–40.1] 37.7 [36.7–38.7] 37.4 [35.3–39.4]
Range (nEq/L) 4.2 [3.3–5.1] 2.9 [2.4–3.4] 3.1 [2.6–3.6]
Cerebrovascular CO2 reactivity (%/nEq/L) 6.4 [4.5–8.4] 11.4* [9.3–13.5] 14.1* [11.2–17.1]
Different from SL (*) and ALT1 († ), P < 0.05.
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FIGURE 3 | Modified rebreathing parameters at sea level (SL), upon ascent (ALT1), and following 16 days acclimatization to 5260m (ALT16). Data
expressed as mean ± 95% confidence interval. * different from SL (P < 0.05); † different from ALT1 (P < 0.05).
severe hypocapnia associated with prolonged exposure to high
altitude.
CBF regulation during both acute and chronic hypoxia can
be summarized as the net effect of hypoxia-induced vasodilation
and hypocapnia-induced vasoconstriction of the cerebral blood
vessels (Xu and Lamanna, 2006; Brugniaux et al., 2007).
During initial exposure to severe hypoxia, the vasodilatory
drive in the cerebral blood vessels typically exceeds that of
the constrictor drive, thereby elevating CBF (Severinghaus
et al., 1966; Subudhi et al., 2014c). During acclimatization,
the progressive increase in ventilatory drive lowers PaCO2 and
elevates PaO2 (Brugniaux et al., 2007), resulting in greater
vasoconstrictor drive and restoring of CBF to pre-exposure
values (Severinghaus et al., 1966; Subudhi et al., 2014c). In
the absence of a cerebrovascular resetting, the progressive
increase in ventilatory drive and associated hyperventilation-
induced hypocapnia with acclimatization would eventually lead
to cerebral hypoperfusion. Therefore, the observed resetting
of cerebrovascular CO2 reactivity to a lower PCO2 operating
point mitigates the adverse effects of hypocapnia-induced
vasoconstriction, thus enabling the cerebral vessels to better
regulate CBF during prolonged high altitude exposure.
Altered Acid-Base Buffering
The CSF is a bicarbonate-containing fluid which acts as an
important acid-base buffer in the regulation in CSF pH (Siesjö,
1972). Since there are negligible concentrations of protein
and other non-bicarbonate buffers in the CSF (Davson, 1967),
changes in [HCO−3 ] reflect changes in buffer base (Siesjö,
1972). As elegantly summarized by Fencl et al. (1969), the
regulation of CBF and ventilation are components of the
same homeostatic system, where the input consists of [H+] in
the CSF compartment, which is determined by [HCO−3 ] and
PCO2. In this system, the respiratory loop regulates PaCO2
(and therefore [H+] controlling CBF), while the cerebrovascular
loop regulates the PCO2 gradient between arterial and CSF
compartment (and therefore [H+] at the level of the central
chemoreceptors). Importantly, the bicarbonate concentration
provides the link between the two regulatory loops of this
system. Under conditions of metabolic acidosis or alkalosis,
CSF [HCO−3 ] is regulated to reduce CSF pH variations to
one tenth of that occurring in the arterial compartment
(Fencl et al., 1969; Dempsey et al., 1978). Since a CSF pH
change of 0.2 unit covers the entire ventilatory response from
life-threatening hypoventilation to maximal hyperventilation
(Pappenheimer, 1967), a close regulation of CSF pH is critical
for normal respiratory function. As CSF [HCO−3 ] is an important
link between cerebrovascular and ventilatory control, any
bicarbonate-mediated changes in ventilatory CO2 sensitivity
should be reflected in cerebrovascular CO2 reactivity. Moreover,
changes in CSF [HCO−3 ] would lead to proportional changes in
the PCO2 range within which CBF and ventilation are regulated.
In support, we found there was a leftward shift of the PaCO2-
[H+] relationship at ALT16 (Table 1).
Enhanced Sensitivity to H+ during Acute Exposure
During respiratory alkalosis, as observed during hypoxic
exposure, a reduced CSF [HCO−3 ] leads to a greater increase
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FIGURE 4 | Fitting of the individual (dotted line) and group (solid line)
MCAv response to PETCO2 (A) and [H
+] (B) during modified
rebreathing at sea level (SL), upon ascent (ALT1), and following 16 days
acclimatization to 5260m (ALT16). Our data indicates that when MCAv is
plotted against [H+] rather than PETCO2, the leftward shift in the sigmoid
curve at ALT16 is abolished. Moreover, (B) demonstrates that the midpoints of
the sigmoid curves are around 37 nEq/L regardless of the altitude or
acclimatization status.
in [H+] for a given rise in PaCO2 (Siesjö, 1972). Previously,
we speculated these changes in acid-base buffering following
prolonged hypoxic exposure could account for the enhanced
cerebrovascular CO2 reactivity during initial exposure to
high altitude (Fan et al., 2010). Accordingly, any increase
in cerebrovascular CO2 reactivity at high altitude should be
abolished when plotting MCAv changes against [H+] instead
of PCO2. However, in the present analysis we found the
increase in sigmoid slope at ALT1 persisted when we plotted
MCAv against [H+] (Figure 4B), which indicates that this
increase in cerebrovascular CO2 reactivity upon ascent to
high altitude is mediated by an enhanced H+ sensitivity in
the cerebral vasculature per se, rather than altered acid-base
balance only.
The presence of a cerebrovascular function resetting at high
altitude was first alluded to by Severinghaus (1965) and later
by Fan et al. (2010). In support, early work by Fencl et al.
(1969) reported leftward shifts in both cerebrovascular and
ventilation responses to CO2 following a 5 day administration
of sodium bicarbonate (inducing metabolic alkalosis), while
chronic metabolic acidosis with ammonium chloride elicited an
opposite effect on these CO2 responses. High altitude studies
have reported a leftward shift in the ventilatory response
to CO2 (Crawford and Severinghaus, 1978; Mathew et al.,
1983; Somogyi et al., 2005; Ainslie and Burgess, 2008; Fan
et al., 2010), which can be predicted by modeling the acid-
base changes in the CSF compartment (Duffin, 2005). Using
CO2 supplementation, Cruz et al. (1980) demonstrated that
the leftward shift in the ventilatory response to CO2 observed
following 75 h of altitude exposure can be abolished by
preventing the respiratory alkalosis (and subsequent negative
base excess). These findings suggest that the changes in acid-
base balance are responsible for the resetting of resting CBF
and the leftward shifts in both cerebrovascular and ventilatory
responses to CO2 during acclimatization to high altitude. In
the present study, the leftward shift in the cerebrovascular CO2
reactivity at ALT16 was abolished when the MCAv changes
were plotted against [H+] instead of PETCO2 (Figure 4). As a
result, the midpoints of the sigmoid curves appeared at similar
[H+] (∼37 nEq/L) across all three time-points (Figure 4B).
From this, we speculate that the observed leftward shift of the
sigmoid curve at ALT16 is likely a consequence of reduced
[HCO−3 ] in the CSF, resulting from the prolonged exposure to
hypoxia-induced hypocapnia. Moreover, our findings indicate
that the cerebral reserves for vasoconstriction and vasodilation
are most optimal around 37 nEq/L H+ concentration, regardless
of altitude or acclimatization status. Our data support the
notion that H+-mediated cerebrovascular control is highly
conserved.
Altered Cerebrovascular Reserves at High
Altitude
The midpoint of the sigmoid cerebrovascular reactivity
curve represents the optimization point between maximal
vasoconstriction and vasodilation (Battisti-Charbonney et al.,
2011). A departure of resting PaCO2 from the midpoint
toward the lower plateau lowers the vascular reserve for
further constriction, while increasing PaCO2 toward the upper
plateau lowers the vascular reserve for dilation (Figure 4A). In
addition, outside the linear portion of the sigmoid curve, the
CBF responsiveness to changes in CO2 is blunted. Together
these changes in PaCO2 and associated reductions in vascular
reserve for constriction and dilation limit the blood vessels’
ability to regulate CBF against perturbations in either PaCO2
or ABP. As reported in our previous study (Subudhi et al.,
2014a), hyperventilation at 5260m lowered resting PaCO2
by ∼12mmHg at ALT1 and by ∼17mmHg at ALT16. These
reductions in resting PaCO2 lowered the vascular constriction
reserve by ∼30% upon ascent to 5260m and following
acclimatization, despite the compensatory leftward shift in the
cerebrovascular CO2 reactivity curve at ALT16 (Figure 4A).
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Our present findings indicate that hyperventilation-induced
hypocapnia reduced the vascular reserve for vasoconstriction
at high altitude, thereby blunting the vessel’s ability to respond
to changes in CO2 (and presumably blood pressure) at
5260 m. Importantly, this reduced vascular reserve and
associated blunting of the cerebral vessels’ responsiveness could
potentially account for the impaired cerebral autoregulation
observed during acute and chronic exposure to hypoxia, as
previously reported by Subudhi et al. (2014b) and others
(Jansen et al., 2000; Ainslie et al., 2008; Iwasaki et al.,
2011).
Confounding Influence of Background
Hypoxia and Blood Pressure
The effect of high altitude exposure on cerebrovascular CO2
reactivity has been examined by a number of studies (Jensen
et al., 1996; Jansen et al., 1999; Ainslie and Burgess, 2008;
Fan et al., 2010, 2012, 2014; Lucas et al., 2011; Villien et al.,
2013; Rupp et al., 2014; Flück et al., 2015; Willie et al.,
2015). More recently, studies have assessed cerebrovascular
CO2 reactivity in background hypoxia (Rupp et al., 2014; Flück
et al., 2015; Willie et al., 2015), which has been shown to
blunt the CBF response to CO2 (McPherson et al., 1987; Fan
et al., 2013; Ogoh et al., 2014)—presumably by exhausting the
dilatory response and reducing prostanoid synthesis (Leﬄer
et al., 1986). Those studies have found cerebrovascular CO2
reactivity to be either reduced (Rupp et al., 2014; Flück
et al., 2015), or unchanged (Willie et al., 2015) following
ascent to high altitude, while ventilatory responsiveness to CO2
was enhanced. In contrast, studies assessing cerebrovascular
CO2 reactivity in background hyperoxia have consistently
found it to be elevated with high altitude ascent (Fan
et al., 2010, 2012, 2014) and prolonged exposure to hypoxia
(Poulin et al., 2002), coinciding with enhanced ventilatory
CO2 sensitivity. Due to the confounding effects of hypoxia,
the cerebrovascular responses to CO2 assessed in background
hypoxia may not necessarily reflect true cerebrovascular
CO2 reactivity per se and thus should be interpreted with
caution.
In agreement with our previous report using linear fitting
(Fan et al., 2014), we found cerebrovascular CO2 reactivity to
be enhanced by 85% upon ascent at ALT1, while no further
increased was observed following the acclimatization period
in this study (Table 1). Similar to other high altitude studies
(Flück et al., 2015; Willie et al., 2015), we observed large
elevations in blood pressure during CO2 breathing (Fan et al.,
2014). Since increases in systemic blood pressure influence
the CBF response to CO2 (Betz, 1968) and thus confounds
the measurement of cerebrovascular CO2 reactivity (Regan
et al., 2014), we attribute this smaller additional increase in
cerebrovascular CO2 reactivity at ALT16 to the constant ABP
during the rebreathing trials analyzed in this study. Therefore,
it should be acknowledged that the previously reported changes
of cerebrovascular CO2 reactivity at high altitude reflect the
CBF response to the combined effects of both CO2 and
arterial blood pressure, rather than CO2 alone. However,
we cannot exclude the possibility that the lack of increase
at ALT16 compared to ALT1 may be due a lower subject
number.
Limitations
One of the critiques when using TCD-measured MCAv as an
index of CBF is the assumption that middle cerebral artery
(MCA) diameter does not change. Due to the exponential
dependency of the vessel cross-sectional area on the diameter,
small changes in MCA diameter would result in considerable
errors in CBF estimates with TCD. As mentioned in our
previous study (Fan et al., 2014), we assessed MCAv changes
in a background of hyperoxia (PETO2 >250mmHg), thus
excluding any confounding dilatory effects of hypoxia on MCA
diameter in our measurements. While early magnetic resonance
imaging (MRI) studies found no changes in MCA diameter
during changes in PETCO2 between 24 and 45mmHg (Valdueza
et al., 1997; Serrador et al., 2000), more recent and higher
resolution MRI studies reported changes in MCA diameter (1.2–
8%) during voluntary hyperventilation (PETCO2: 27–24mmHg)
and hypercapnia (PETCO2: 45–51mmHg) (Coverdale et al.,
2014; Verbree et al., 2014). The major implications of these
MCA diameter changes are overestimation of CBF at low PaCO2,
and underestimation of CBF at high PaCO2 with TCD. In
agreement, Willie et al. (2015) found TCD to underestimate
cerebrovascular CO2 reactivity when compared to the vascular
Doppler ultrasound method. However, we contend that our
assessment of CBF with TCD estimates are reliable since: (i)
Caputi et al. (2014) have shown similar values of cerebrovascular
CO2 reactivity using MRI and TCD estimates of CBF response
to 5% CO2 breathing; and (ii) all the temporal indices such
as the midpoint and range of the sigmoid curve would be
unaffected by any underestimation of CBF with TCD. Another
important consideration when interpreting our findings is our
use of arterial pH and acid-base buffering as a surrogate for CSF
pH changes at high altitude. Dempsey et al. (1974) previously
reported consistent pH differences (∼0.08), and similar [HCO−3 ]
between arterial and lumbar spinal fluid in seven subjects at sea-
level, and following 1, 8 h, and 3–4 weeks at 3100m. Moreover,
they found identical pH compensation (66%) in both arterial
and lumbar spinal fluid compartments following acclimatization
to high altitude. The data from Dempsey et al. (1974) thus
support the use of arterial acid-base changes as an index
of CSF changes during acute and chronic exposure to high
altitude.
CONCLUSION
The present study is the first to demonstrate a remodeling
of the sigmoid cerebrovascular CO2 reactivity curve following
acclimatization to high altitude. Our data indicates that the
increase in cerebrovascular CO2 reactivity upon ascent to
high altitude is mediated by enhanced H+ sensitivity of the
cerebral vasculature. Meanwhile, acclimatization to 5260m leads
to a leftward shift in cerebrovascular CO2 reactivity which
appears to be mediated by an altered acid-base buffering
following prolonged exposure to hypoxia. We speculate that
such cerebrovascular resetting is critical for maintaining normal
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cerebrovascular control and preventing cerebral hypoperfusion
from the prolonged severe hypocapnia associated with high
altitude acclimatization.
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